Italian innovation consultancy specializing in research commercialization, investor readiness, and exploitation planning across EU-funded projects.
META Group is an Italian innovation consultancy that helps EU-funded research projects reach the market — bridging the gap between lab results and investors, customers, and commercial viability. They specialize in business acceleration services: investor readiness, commercialization roadmaps, market access strategies, and ecosystem building for SMEs and research spin-offs. With 11 of their 16 H2020 projects being Coordination and Support Actions (CSA), their role is not to do the research itself but to ensure research results find commercial pathways. They operate across multiple sectors — from eHealth to bioeconomy to advanced materials — always in the role of business support and innovation management.
FET2RIN (coordinator, supporting FET projects to reach investors), ESIL (coordinator, early-stage investing), MagElastic (commercialisation roadmap, lean canvas, access to investors), ACE Creative (access to finance), WhiteRabbit.
SCHIP (coordinator, EUR 2.86M Social Challenges Innovation Platform), ACE Creative (innovation multiplier for creative SMEs), eHealth Hub (European business support hub), ESIL (unleashing early-stage investing potential).
RI-LINKS2UA (strengthening R&I links with Ukraine) and cross-border ecosystem work in ESIL (cross-border investments, local champions).
POWER4BIO (empowering regional bioeconomy) and RADIANT (dynamic value chains for underutilised crops) — both as participant providing dissemination and market engagement.
re-MODULEES (retrofitting market activation platform) and ECO2Fuel (low-temperature CO2 conversion to fuels) — contributing business development and exploitation planning.
In 2015–2018, META Group focused squarely on startup and SME acceleration: helping FET projects find investors (FET2RIN), building innovation platforms (SCHIP), and supporting creative industries and eHealth ventures with market access and finance tools. From 2019 onward, they diversified into domain-specific sectors — bioeconomy (POWER4BIO, RADIANT), energy renovation (re-MODULEES), green fuels (ECO2Fuel), and medical diagnostics (MagElastic, AIR3D) — while still performing the same core function of commercialization support. The shift shows a consultancy that maintained its business model but expanded from generic innovation support into thematic EU priority areas like the Green Deal and health.
META Group is embedding its innovation management expertise into Green Deal and health projects, positioning itself as a go-to exploitation partner for thematic research consortia.
META Group primarily joins as a participant (13 of 16 projects), typically handling exploitation, dissemination, and business planning work packages rather than leading entire consortia. When they do coordinate (SCHIP, FET2RIN, ESIL), the projects are CSA-type innovation support initiatives — their natural home turf. With 145 unique partners across 29 countries, they are a high-connectivity hub rather than a loyal-partner organization, which reflects their role as a professional services firm that adapts to new consortia for each call.
With 145 unique consortium partners spanning 29 countries, META Group has one of the broadest networks you'd expect from a mid-size consultancy — a result of joining diverse thematic projects across nearly every H2020 pillar. Their geographic reach is pan-European with no strong regional bias.
META Group fills a specific niche: they are not researchers and not pure management consultants, but sit exactly at the research-to-market junction. For consortium builders, they bring a proven track record in exploitation planning, investor engagement, and business model design — the work packages that reviewers want to see done by professionals, not by researchers as an afterthought. Their cross-sector flexibility (health, energy, food, digital) means they can credibly support commercialization in almost any thematic area.
